Gestational breast cancer (GBC) is the second most commonly occurring malignancy affecting pregnant women. Management is complex due to potential foetal risks in the setting of maternal treatment. We report on the maternal, foetal, short-term neonatal and placental histopathologic findings of a retrospective cohort of pregnant women with either pre-gestational (group 1) or GBC (group 2) from a tertiary-level maternity care centre. Of the 69 women identified over 12 years, there were 47 in group 1 and 22 in group 2. Demographics, stage of breast cancer at diagnosis were similar in the 2 groups. Women with GBC (group 2) were more likely to receive surgery and chemotherapy or surgery alone as compared to those in group 1. No women with GBC received radiation during pregnancy, but 2 received this treatment postpartum. With regard to pregnancy outcomes, induction of labour was more common in women with GBC, as was preterm birth. Most preterm birth in women with GBC was late preterm, iatrogenic in nature to facilitate postpartum treatment. We conclude comparable pregnancy outcomes for women with GBC as compared to those with pregestational breast cancer.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000493128 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Gestational breast cancer: distinctive molecular and clinico-epidemiological features.
J Mammary Gland Biol Neoplasia
November 2024
GEICAM Spanish Breast Cancer Group, Madrid, Spain.
Gestational breast cancer (GBC), defined as breast cancer (BC) diagnosed during pregnancy or the first-year post-partum, accounts for 6-15% of BC cases in women aged 20-44 years. GBC has worse prognosis than non-GBC, but reasons behind are not clear. The GEICAM/2012-03 Study (Molecular Characterization of Gestational Breast Cancer) is a multicenter prospective/retrospective observational registry of patients diagnosed with GBC.
View Article and Find Full Text PDFAn Artificial Intelligence Approach for Test-Free Identification of Sarcopenia.
J Cachexia Sarcopenia Muscle
December 2024
Department of Nephrology, Chongqing Key Laboratory of Prevention and Treatment of Kidney Disease, Chongqing Clinical Research Center of Kidney and Urology Diseases, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
Background: The diagnosis of sarcopenia relies extensively on human and equipment resources and requires individuals to personally visit medical institutions. The objective of this study was to develop a test-free, self-assessable approach to identify sarcopenia by utilizing artificial intelligence techniques and representative real-world data.
Methods: This multicentre study enrolled 11 661 middle-aged and older adults from a national survey initialized in 2011.
Impact of Retroperitoneal Lymphadenopathy (RPLN) on the Outcomes of Locally Advanced Gall Bladder Cancer (GBC) Following Chemotherapy (CT) or Chemotherapy Followed by Consolidation Chemoradiotherapy (CTRT).
J Gastrointest Cancer
October 2024
Department of Radiotherapy, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, 226014, India.
Article Synopsis
- The study investigates the outcomes of gallbladder cancer (GBC) patients with retroperitoneal lymphadenopathy (RPLN), analyzing their response to treatment via chemotherapy followed by consolidation chemoradiotherapy (CTRT).
- It focuses on a group of 189 patients, of which 80 had RPLN, comparing their treatment responses and overall survival rates to those without RPLN, noting their similar demographic characteristics.
- Results indicated that while both groups had comparable response rates to treatment, overall survival was further analyzed using statistical methods, highlighting a complex treatment dilemma for patients with RPLN in locally advanced non-metastatic GBC.
Reconsidering Routine Histopathological Examination of Gallbladder Specimens in Cholecystectomy: Optimizing Clinical Practice and Resource Management.
Cureus
July 2024
Department of Surgery, Redland Hospital, Bayside Health Service, Redland, AUS.
Article Synopsis
- Cholecystectomy, the surgical removal of the gallbladder, commonly includes routine histopathological examination (HPE) to check for potential pathologies like gallbladder cancer (GBC), despite some cases showing no visible abnormalities.
- This study, conducted at Redland Hospital in Australia, evaluated the need for routine HPE by analyzing data from gallbladder specimens collected between January and December 2023, focusing on various factors including patient demographics, surgical indications, and cancer outcomes.
- A total of 266 gallbladder specimens were examined, revealing a predominant female patient population and highlighting the distinctions between elective and emergency surgeries, with data suggesting a practice variation in HPE based on cancer risk and available resources globally
Cholecystectomy and digestive cancer in Chile: Complementary results from interrupted time series and aggregated data analyses.
Int J Cancer
January 2025
Statistical Genetics Research Group, Institute of Medical Biometry, Heidelberg University, Heidelberg, Germany.
Gallbladder cancer (GBC) mortality in Chile is among the highest worldwide. In 2006, the Chilean government launched a programme guaranteeing access to gallbladder surgery (cholecystectomy) for patients aged 35-49 years. We evaluated the impact of this programme on digestive cancer mortality.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!